vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and AstroNova, Inc. (ALOT). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $39.2M, roughly 1.1× AstroNova, Inc.). AstroNova, Inc. runs the higher net margin — 1.0% vs -19.9%, a 20.9% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -3.4%). AstroNova, Inc. produced more free cash flow last quarter ($3.3M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 2.1%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
AstroNova, Inc. is a global technology firm designing, manufacturing and distributing specialty data visualization products, including high-performance label printers, test and measurement equipment, and aerospace-grade data recording systems, serving aerospace, manufacturing, retail and healthcare markets worldwide.
ABCL vs ALOT — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $39.2M |
| Net Profit | $-8.9M | $378.0K |
| Gross Margin | — | 36.2% |
| Operating Margin | -63.7% | 3.3% |
| Net Margin | -19.9% | 1.0% |
| Revenue YoY | 788.4% | -3.4% |
| Net Profit YoY | 73.9% | 221.5% |
| EPS (diluted) | $-0.03 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $39.2M | ||
| Q3 25 | $9.0M | $36.1M | ||
| Q2 25 | $17.1M | $37.7M | ||
| Q1 25 | $4.2M | — | ||
| Q4 24 | $5.0M | $40.4M | ||
| Q3 24 | $6.5M | $40.5M | ||
| Q2 24 | $7.3M | $33.0M | ||
| Q1 24 | $10.0M | $39.6M |
| Q4 25 | $-8.9M | $378.0K | ||
| Q3 25 | $-57.1M | $-1.2M | ||
| Q2 25 | $-34.7M | $-376.0K | ||
| Q1 25 | $-45.6M | — | ||
| Q4 24 | — | $240.0K | ||
| Q3 24 | $-51.1M | $-311.0K | ||
| Q2 24 | $-36.9M | $1.2M | ||
| Q1 24 | $-40.6M | $2.7M |
| Q4 25 | — | 36.2% | ||
| Q3 25 | — | 32.2% | ||
| Q2 25 | — | 33.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 35.3% | ||
| Q2 24 | — | 36.3% | ||
| Q1 24 | — | 31.9% |
| Q4 25 | -63.7% | 3.3% | ||
| Q3 25 | -851.8% | -2.0% | ||
| Q2 25 | -290.2% | 1.5% | ||
| Q1 25 | -1479.6% | — | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | -1439.4% | 2.6% | ||
| Q2 24 | -1276.2% | 4.1% | ||
| Q1 24 | -551.5% | 9.9% |
| Q4 25 | -19.9% | 1.0% | ||
| Q3 25 | -637.8% | -3.4% | ||
| Q2 25 | -203.3% | -1.0% | ||
| Q1 25 | -1077.2% | — | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | -785.4% | -0.8% | ||
| Q2 24 | -504.3% | 3.6% | ||
| Q1 24 | -408.0% | 6.8% |
| Q4 25 | $-0.03 | $0.05 | ||
| Q3 25 | $-0.19 | $-0.16 | ||
| Q2 25 | $-0.12 | $-0.05 | ||
| Q1 25 | $-0.15 | — | ||
| Q4 24 | — | $0.03 | ||
| Q3 24 | $-0.17 | $-0.04 | ||
| Q2 24 | $-0.13 | $0.15 | ||
| Q1 24 | $-0.14 | $0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $3.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $76.9M |
| Total Assets | $1.4B | $140.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $3.6M | ||
| Q3 25 | $83.2M | $3.9M | ||
| Q2 25 | $92.4M | $5.4M | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | $4.4M | ||
| Q3 24 | $126.6M | $4.8M | ||
| Q2 24 | $148.3M | $4.0M | ||
| Q1 24 | $123.6M | $4.5M |
| Q4 25 | $966.9M | $76.9M | ||
| Q3 25 | $964.0M | $75.8M | ||
| Q2 25 | $1.0B | $76.6M | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $1.1B | $92.2M | ||
| Q3 24 | $1.1B | $91.8M | ||
| Q2 24 | $1.1B | $91.2M | ||
| Q1 24 | $1.1B | $90.3M |
| Q4 25 | $1.4B | $140.8M | ||
| Q3 25 | $1.4B | $143.1M | ||
| Q2 25 | $1.4B | $150.3M | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | $166.5M | ||
| Q3 24 | $1.4B | $169.0M | ||
| Q2 24 | $1.4B | $126.6M | ||
| Q1 24 | $1.5B | $133.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $3.4M |
| Free Cash FlowOCF − Capex | $-44.6M | $3.3M |
| FCF MarginFCF / Revenue | -99.4% | 8.5% |
| Capex IntensityCapex / Revenue | 21.9% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.05× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $3.4M | ||
| Q3 25 | $-52.6M | $249.0K | ||
| Q2 25 | $-32.4M | $4.4M | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | $-108.6M | $-4.7M | ||
| Q3 24 | $-28.9M | $162.0K | ||
| Q2 24 | $-30.0M | $6.9M | ||
| Q1 24 | $-41.7M | $6.5M |
| Q4 25 | $-44.6M | $3.3M | ||
| Q3 25 | $-61.5M | $202.0K | ||
| Q2 25 | $-45.8M | $4.3M | ||
| Q1 25 | $-22.2M | — | ||
| Q4 24 | $-187.0M | $-5.0M | ||
| Q3 24 | $-47.4M | $-176.0K | ||
| Q2 24 | $-50.1M | $6.4M | ||
| Q1 24 | $-65.8M | $6.0M |
| Q4 25 | -99.4% | 8.5% | ||
| Q3 25 | -687.0% | 0.6% | ||
| Q2 25 | -267.9% | 11.5% | ||
| Q1 25 | -524.0% | — | ||
| Q4 24 | -3702.8% | -12.4% | ||
| Q3 24 | -728.4% | -0.4% | ||
| Q2 24 | -683.8% | 19.5% | ||
| Q1 24 | -661.5% | 15.3% |
| Q4 25 | 21.9% | 0.2% | ||
| Q3 25 | 99.7% | 0.1% | ||
| Q2 25 | 78.2% | 0.2% | ||
| Q1 25 | 251.1% | — | ||
| Q4 24 | 1552.7% | 0.6% | ||
| Q3 24 | 284.6% | 0.8% | ||
| Q2 24 | 274.6% | 1.5% | ||
| Q1 24 | 242.5% | 1.0% |
| Q4 25 | — | 9.05× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -19.76× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.85× | ||
| Q1 24 | — | 2.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
ALOT
| Public Utilities Inventory Supplies | $20.6M | 53% |
| Hardware Products | $12.7M | 32% |
| Service And Other | $5.9M | 15% |
